OTC Markets OTCQB - Delayed Quote USD

ZIVO Bioscience, Inc. (ZIVO)

Compare
18.00 +0.40 (+2.27%)
At close: 3:39:16 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
79.02
27.65
--
--
20.00
Cost of Revenue
52.94
16.04
--
--
--
Gross Profit
26.08
11.61
--
--
--
Operating Expense
13,688.15
7,274.62
8,731.97
8,645.12
8,575.68
Operating Income
-13,662.06
-7,263.01
-8,731.97
-8,645.12
-8,555.68
Net Non Operating Interest Income Expense
-29.94
-514.17
-13.32
-233.28
-550.05
Other Income Expense
--
--
--
122.52
--
Pretax Income
-13,692.00
-7,777.18
-8,745.29
-8,755.88
-9,105.73
Net Income Common Stockholders
-13,692.00
-7,777.18
-8,745.29
-8,755.88
-9,105.73
Diluted NI Available to Com Stockholders
-13,692.00
-7,777.18
-8,745.29
-8,755.88
-9,105.73
Basic EPS
-4.83
-4.60
-5.57
-6.90
-10.58
Diluted EPS
-4.83
-4.60
-5.57
-6.90
-10.58
Basic Average Shares
2,762.96
1,690.01
1,569.94
1,271.51
860.49
Diluted Average Shares
2,762.96
1,690.01
1,569.94
1,271.51
860.49
Total Operating Income as Reported
-13,662.06
-7,263.01
-8,731.97
-8,645.12
-8,555.68
Total Expenses
13,741.08
7,290.66
8,731.97
8,645.12
8,575.68
Net Income from Continuing & Discontinued Operation
-13,692.00
-7,777.18
-8,745.29
-8,755.88
-9,105.73
Normalized Income
-13,692.00
-7,777.18
-8,745.29
-8,878.40
-9,105.73
Interest Expense
29.94
514.17
13.32
233.28
550.05
Net Interest Income
-29.94
-514.17
-13.32
-233.28
-550.05
EBIT
-13,662.06
-7,263.01
-8,731.97
-8,522.60
-8,555.68
EBITDA
-13,662.06
-7,263.01
-8,731.97
-8,522.60
-8,555.68
Reconciled Cost of Revenue
52.94
16.04
--
--
--
Net Income from Continuing Operation Net Minority Interest
-13,692.00
-7,777.18
-8,745.29
-8,755.88
-9,105.73
Total Unusual Items Excluding Goodwill
0.82
--
--
122.52
--
Total Unusual Items
0.82
--
--
122.52
--
Normalized EBITDA
-13,662.06
-7,263.01
-8,731.97
-8,645.12
-8,555.68
12/31/2020 - 12/15/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INDP Indaptus Therapeutics, Inc.
0.9380
+5.39%
 
GNFT Genfit S.A.
3.8000
+2.15%
 
RLYB Rallybio Corporation
0.9500
-2.68%
 
LIDDS.ST LIDDS AB (publ)
0.1045
-0.95%
 
ONC.L Oncimmune Holdings plc
14.90
+0.68%
 
NANECH.ST NanoEcho AB
0.1580
+21.54%
 
EMBT Ember Therapeutics, Inc.
0.0001
0.00%
 
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
 
INNMF Amplia Therapeutics Limited
0.0550
-21.43%
 
COMBI.ST CombiGene AB (publ)
2.7200
+5.43%